REC-4881 is among the first AI-enabled programs to advance a registrational Phase 3 trial design for a disease with no approved pharmacologic therapies. Its potential as a first-in-class oral therapy ...
Have you ever sat back and wondered how much of our digital world relies on a simple roll of the dice? Whether it''s the loot ...
The "Subject B" exam, which consists of 20 questions to be solved in 100 minutes, significantly impacts whether you pass or ...
Box ManipulationIn the history of artificial intelligence and machine learning, the determination of internal parameters ...
System logs generated by globally distributed microservices often hide subtle degradations (like memory thrashing or systemic ...
A new Python package provides programmatic access to tens of thousands of uniformly processed RNA-seq samples from human and mouse through APIs, command-line tools and analysis-ready data structures.
Recursion said it expects to launch its first registrational trial in the second half of this year for its lead candidate REC-4881 based on talks with the FDA, after the oral familial adenomatous ...
Anthropic claims to be near something along the lines of recursive self-improvement, or RSI, according to the latest revision of its S-1/A filing, published Monday. The new warning in the “Risk ...